Abstract
Renal ischemia-reperfusion injury (IRI) is regarded as a leading cause of acute kidney failure and renal dysfunction. Previous studies show that kappa opioid receptor (KOR) agonists can attenuate IRI in cardiomycytes and neuronal cells. In this study we explored the effects of a KOR agonist on renal IRI and the underlying mechanisms in vivo and in vitro. An IRI model was established in SD rats, which were intravenously pretreated with a KOR agonist U50448H (1 mg/kg), a KOR antagonist Nor-BNI (2 mg/kg) followed by U50448H (1 mg/kg), or the PI3K inhibitor wortmannin (1.4 mg/kg) followed by U50448H (1 mg/kg). U50448H pretreatment significantly decreased the serum levels of creatinine (Cr) and BUN, the renal tubular injury scores and the apoptotic index (AI) in IRI model rats. Furthermore, U50448H significantly increased SOD activity and NO levels, and reduced the MDA levels in the kidney tissues of IRI model rats. Moreover, U50448H significantly increased the phosphorylation of Akt, eNOS and PI3K in the kidney tissues of IRI model rats. All the beneficial effects of U50448H were blocked by Nor-BNI or wortmannin pre-administered. Similar results were observed in vitro in renal tubular epithelial NRK-52E cells subjected to a hypoxia-reoxygenation (HR) procedure. Our results demonstrate that the KOR agonist U50448H protects against renal IRI via activating the PI3K/Akt signaling pathway.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847–59.
Chatterjee PK . Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 2007; 376: 1–43.
Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005; 115: 2894–903.
Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ, et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003; 14: 1188–99.
Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000; 105: 1363–71.
Selzner N, Rudiger H, Graf R, Clavien PA . Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917–36.
Lin JY, Hung LM, Lai LY, Wei FC . Kappa-opioid receptor agonist protects the microcirculation of skeletal muscle from ischemia reperfusion injury. Ann Plast Surg 2008; 61: 330–6.
Chunhua C, Chunhua X, Megumi S, Renyu L . Kappa Opioid Receptor Agonist and Brain Ischemia. Transl Perioper Pain Med 2014; 1: 27–34.
Bruchas MR, Chavkin C . Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl) 2010; 210: 137–47.
Munro TA, Rizzacasa MA, Roth BL, Toth BA, Yan F . Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist. J Med Chem 2005; 48: 345–8.
Lokensgard JR, Gekker G, Peterson PK . Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4+ lymphocytes. Biochem Pharmacol 2002; 63: 1037–41.
McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ . Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacol Biochem Behav 2006; 83: 109–13.
Wang JK, Yu LN, Zhang FJ, Yang MJ, Yu J, Yan M, et al. Post-conditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res 2010; 1357: 142–51.
Xu MC, Shi HM, Gao XF, Wang H . Salidroside attenuates myocardial ischemia-reperfusion injury via PI3K/Akt signaling pathway. J Asian Nat Prod Res 2013; 15: 244–52.
Zhang J, Yao Y, Xiao F, Lan X, Yu C, Zhang Y, et al. Administration of dexamethasone protects mice against ischemia/reperfusion induced renal injury by suppressing PI3K/AKT signaling. Int J Clin Exp Pathol 2013; 6: 2366–75.
Zhang G, Wang Q, Zhou Q, Wang R, Xu M, Wang H, et al. Protective Effect of Tempol on Acute Kidney Injury Through PI3K/Akt/Nrf2 Signaling Pathway. Kidney Blood Press Res 2016; 41: 129–38.
Zhu YM, Wang CC, Chen L, Qian LB, Ma LL, Yu J, et al. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res 2013; 1494: 1–8.
Brent PJ, Bot G . Morphine, D-Pen2, D-Pen5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs. Psychopharmacology (Berl) 1992; 107: 581–90.
Wang Q, Sun Y, Li J, Xing W, Zhang S, Gu X, et al. Quaternary ammonium salt of U50488H, a new kappa-opioid receptor agonist, protects rat heart against ischemia/reperfusion injury. Eur J Pharmacol 2014; 737: 177–84.
Chang B, Sang L, Wang Y, Tong J, Wang B . The role of FoxO4 in the relationship between alcohol-induced intestinal barrier dysfunction and liver injury. Int J Mol Med 2013; 31: 569–76.
Paller MS, Hoidal JR, Ferris TF . Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156–64.
Brownhill S, Cohen D, Burchill S . Proliferation index: a continuous model to predict prognosis in patients with tumours of the Ewing's sarcoma family. PLoS One 2014; 9: e104106.
Zheng Y, Lu M, Ma L, Zhang S, Qiu M, Wang Y . Osthole ameliorates renal ischemia-reperfusion injury in rats. J Surg Res 2013; 183: 347–54.
Jiang B, Liu X, Chen H, Liu D, Kuang Y, Xing B, et al. Ischemic postconditioning attenuates renal ischemic/reperfusion injury in mongrel dogs. Urology 2010; 76: 1519 e1–7.
Stroo I, Stokman G, Teske GJ, Raven A, Butter LM, Florquin S, et al. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int Immunol 2010; 22: 433–42.
Cheung JS, Fan SJ, Chow AM, Zhang J, Man K, Wu EX . Diffusion tensor imaging of renal ischemia reperfusion injury in an experimental model. NMR Biomed 2010; 23: 496–502.
Hioki A, Ohtomo H . Significance of blood urea nitrogen as an index of renal function in mice infected with Plasmodium berghei. Parasitol Res 1989; 76: 127–30.
Palipoch S . A review of oxidative stress in acute kidney injury: protective role of medicinal plants-derived antioxidants. Afr J Tradit Complement Altern Med 2013; 10: 88–93.
Li G, Chen Y, Hu H, Liu L, Hu X, Wang J, et al. Association between age-related decline of kidney function and plasma malondialdehyde. Rejuvenation Res 2012; 15: 257–64.
Senbel AM, AbdelMoneim L, Omar AG . Celecoxib modulates nitric oxide and reactive oxygen species in kidney ischemia/reperfusion injury and rat aorta model of hypoxia/reoxygenation. Vascul Pharmacol 2014; 62: 24–31.
Nakayama H, Akiyama S, Shiotani S, Gotoh H, Inagaki M, Oguchi K . Evaluation of superoxide dismutase activity in dialyzed patients by electron spin resonance spectroscopy. Am J Nephrol 2002; 22: 6–10.
Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, et al. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. J Pharmacol Exp Ther 2005; 312: 220–30.
Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H . Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 2010; 25: 1251–7.
Wang YH, Sun JF, Tao YM, Chi ZQ, Liu JG . The role of kappa-opioid receptor activation in mediating antinociception and addiction. Acta Pharmacol Sin 2010; 31: 1065–70.
Rong F, Peng Z, Ye MX, Zhang QY, Zhao Y, Zhang SM, et al. Myocardial apoptosis and infarction after ischemia/reperfusion are attenuated by kappa-opioid receptor agonist. Arch Med Res 2009; 40: 227–34.
Liu WJ, Tang HT, Jia YT, Ma B, Fu JF, Wang Y, et al. Notoginsenoside R1 attenuates renal ischemia-reperfusion injury in rats. Shock 2010; 34: 314–20.
Granier S, Manglik A, Kruse AC, Kobilka TS, Thian FS, Weis WI, et al. Structure of the delta-opioid receptor bound to naltrindole. Nature 2012; 485: 400–4.
Weber ML, Farooqui M, Nguyen J, Ansonoff M, Pintar JE, Hebbel RP, et al. Morphine induces mesangial cell proliferation and glomerulopathy via kappa-opioid receptors. Am J Physiol Renal Physiol 2008; 294: F1388–97.
Okubo S, Tanabe Y, Takeda K, Kitayama M, Kanemitsu S, Kukreja RC, et al. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor. Am J Physiol Heart Circ Physiol 2004; 287: H1786–91.
Liu HB, Meng QH, Huang C, Wang JB, Liu XW . Nephroprotective effects of polydatin against ischemia/reperfusion injury: a role for the PI3K/Akt signal pathway. Oxid Med Cell Longev 2015; 2015: 362158.
Xu X, Chua CC, Gao J, Chua KW, Wang H . Hamdy RC, et al. Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway. Brain Res 2008; 1227: 12–8.
Kwon DS, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK . Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells. Eur J Cell Biol 2006; 85: 1189–99.
Bruchas MR, Macey TA, Lowe JD, Chavkin C . Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J Biol Chem 2006; 281: 18081–9.
Clayton CC, Xu M, Chavkin C . Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization. J Biol Chem 2009; 284: 31872–81.
Zeynalov E, Nemoto M, Hurn PD, Koehler RC, Bhardwaj A . Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide. J Cereb Blood Flow Metab 2006; 26: 414–20.
Acknowledgements
We would like to give our sincere appreciation to the reviewers for their helpful comments on this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Lj., Yu, Jj. & Xu, Xl. Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K/Akt signaling pathway. Acta Pharmacol Sin 39, 97–106 (2018). https://doi.org/10.1038/aps.2017.51
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/aps.2017.51
Keywords
This article is cited by
-
Anti-inflammatory and renoprotective effects of difelikefalin, a kappa opioid receptor agonist, in a rat model of renal ischemia–reperfusion-induced acute kidney injury
BMC Nephrology (2025)
-
The expression of kappa-opioid receptor promotes the migration of breast cancer cells in vitro
BMC Anesthesiology (2021)
-
Akt1 is involved in tubular apoptosis and inflammatory response during renal ischemia–reperfusion injury
Molecular Biology Reports (2020)
